Sprayable gel with CD47 blockers could be the future of drug delivery for cancer
A sprayable gel containing calcium carbonate nanoparticles with antibodies targeted to block CD47, could be the future of drug delivery for cancer...
List view / Grid view
A sprayable gel containing calcium carbonate nanoparticles with antibodies targeted to block CD47, could be the future of drug delivery for cancer...
In an all-time record year for FDA approvals (48 so far in 2018), Pharmapack Europe reports that innovation is also accelerating across the drug delivery and packaging industries...
A tiny microneedle patch could be the future of delivering therapeutic cell related drugs to the heart of patients after a heart attack...
Researchers have developed a method of producing extracellular vesicles on a large scale to deliver drugs offering a standardised method of manufacture...
IRB researchers have developed a method to use a peptide found in chlorotoxin identified in scorpion venom to deliver drugs through the blood-brain barrier...
31 October 2018 | By PerkinElmer
During this webinar, we will investigate trends seen globally for data integrity violations and avenues for remediation...
Pharmaceutical service provider relies on expanded capacities, modular production and modern analytics...
Direct eye injections treat uveitic macular edema more effectively than treatments placed adjacent to the eye, reveals new Mount Sinai research...
Researchers have developed a tiny, soft drug delivery robot with multiple legs, which is capable of handling and carrying heavy loads...
Record entries highlight a big year of innovation in pharma...
Aluminium could be key for the effective and efficient adsorption of chemotherapy drugs for targeted delivery and reduced side effects...
Researchers have outlined a simple method to increase the number of injection-drug taking individuals with HIV to adhere to their medication...
Researchers have developed an electronic device which could help to detect, prevent and stop seizures from occurring in epileptic patients...
The FDA has approved the first treatment for neurotrophic keratitis, which completely healed the rare disease in 70 percent of cases.
Senescent, or zombie cells, are being targeted with the development of a new nanocarrier drug delivery system.